Estrogen is neuroprotective via an apolipoprotein e-dependent mechanism in a mouse model of global ischemia

K.J. Horsburgh, I.M. Macrae, H.V.O. Carswell

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Estrogen can ameliorate brain damage in experimental models of focal cerebral ischemia. In vitro, estrogen increases levels of apolipoprotein E (apoE), which also has neuroprotective effects in brain injury. The authors tested the hypotheses that physiologically relevant levels of 17-estradiol are neuroprotective in global cerebral ischemia and that neuroprotection is mediated via apoE. In the first study, subcutaneous implants of 17-estradiol were tested in female C57Bl/6J mice (ovariectomized and nonovariectomized) and plasma levels measured by radioimmunoassay to validate that physiologically relevant levels could be achieved. In the second study, female C57Bl/6J and apoE-deficient mice were ovariectomized and implanted with 17-estradiol or placebo pellet. Two weeks later, transient global ischemia was induced by bilateral carotid artery occlusion and the mice killed after 72 hours. Ischemic and normal neurons were counted in the caudate nucleus and CA1 pyramidal cell layer and the percentage of neuronal damage was compared between the treated groups. In C57Bl/6J mice, there was less neuronal damage in the 17-estradiol–treated group compared with placebo group in the caudate nucleus (15 20% versus 39 27%, P = 0.02) and in the CA1 pyramidal cell layer (1.8 2% versus 10 14%, P = 0.08). In contrast, neuronal damage was not significantly different between the 17-estradiol and placebo groups in apoE-deficient mice in the caudate nucleus (47 35% versus 53 29%, P = 0.7) or in the CA1 pyramidal cell layer (24 19% versus 24 19%, P = 1.0). The data indicate a neuroprotective role for estrogen in global ischemia, the mechanism of which is apoE-dependent.
LanguageEnglish
Pages1189-1195
Number of pages7
JournalJournal of Cerebral Blood Flow and Metabolism
Volume22
Issue number10
DOIs
Publication statusPublished - 2002

Fingerprint

Apolipoproteins
Apolipoproteins E
Estradiol
Estrogens
Hippocampal CA1 Region
Ischemia
Caudate Nucleus
Placebos
Brain Ischemia
Neuroprotective Agents
Carotid Arteries
Brain Injuries
Radioimmunoassay
Theoretical Models
Neurons
Brain

Keywords

  • estrogen
  • injury
  • Alzheimer's disease
  • apolipoprotein E
  • neuroprotection
  • global ischemia

Cite this

@article{5c49c774d0664ac59ec809ebd43522db,
title = "Estrogen is neuroprotective via an apolipoprotein e-dependent mechanism in a mouse model of global ischemia",
abstract = "Estrogen can ameliorate brain damage in experimental models of focal cerebral ischemia. In vitro, estrogen increases levels of apolipoprotein E (apoE), which also has neuroprotective effects in brain injury. The authors tested the hypotheses that physiologically relevant levels of 17-estradiol are neuroprotective in global cerebral ischemia and that neuroprotection is mediated via apoE. In the first study, subcutaneous implants of 17-estradiol were tested in female C57Bl/6J mice (ovariectomized and nonovariectomized) and plasma levels measured by radioimmunoassay to validate that physiologically relevant levels could be achieved. In the second study, female C57Bl/6J and apoE-deficient mice were ovariectomized and implanted with 17-estradiol or placebo pellet. Two weeks later, transient global ischemia was induced by bilateral carotid artery occlusion and the mice killed after 72 hours. Ischemic and normal neurons were counted in the caudate nucleus and CA1 pyramidal cell layer and the percentage of neuronal damage was compared between the treated groups. In C57Bl/6J mice, there was less neuronal damage in the 17-estradiol–treated group compared with placebo group in the caudate nucleus (15 20{\%} versus 39 27{\%}, P = 0.02) and in the CA1 pyramidal cell layer (1.8 2{\%} versus 10 14{\%}, P = 0.08). In contrast, neuronal damage was not significantly different between the 17-estradiol and placebo groups in apoE-deficient mice in the caudate nucleus (47 35{\%} versus 53 29{\%}, P = 0.7) or in the CA1 pyramidal cell layer (24 19{\%} versus 24 19{\%}, P = 1.0). The data indicate a neuroprotective role for estrogen in global ischemia, the mechanism of which is apoE-dependent.",
keywords = "estrogen, injury, Alzheimer's disease , apolipoprotein E, neuroprotection, global ischemia",
author = "K.J. Horsburgh and I.M. Macrae and H.V.O. Carswell",
year = "2002",
doi = "10.1097/01.wcb.0000037991.07114.4e",
language = "English",
volume = "22",
pages = "1189--1195",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
number = "10",

}

Estrogen is neuroprotective via an apolipoprotein e-dependent mechanism in a mouse model of global ischemia. / Horsburgh, K.J.; Macrae, I.M.; Carswell, H.V.O.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 22, No. 10, 2002, p. 1189-1195.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Estrogen is neuroprotective via an apolipoprotein e-dependent mechanism in a mouse model of global ischemia

AU - Horsburgh, K.J.

AU - Macrae, I.M.

AU - Carswell, H.V.O.

PY - 2002

Y1 - 2002

N2 - Estrogen can ameliorate brain damage in experimental models of focal cerebral ischemia. In vitro, estrogen increases levels of apolipoprotein E (apoE), which also has neuroprotective effects in brain injury. The authors tested the hypotheses that physiologically relevant levels of 17-estradiol are neuroprotective in global cerebral ischemia and that neuroprotection is mediated via apoE. In the first study, subcutaneous implants of 17-estradiol were tested in female C57Bl/6J mice (ovariectomized and nonovariectomized) and plasma levels measured by radioimmunoassay to validate that physiologically relevant levels could be achieved. In the second study, female C57Bl/6J and apoE-deficient mice were ovariectomized and implanted with 17-estradiol or placebo pellet. Two weeks later, transient global ischemia was induced by bilateral carotid artery occlusion and the mice killed after 72 hours. Ischemic and normal neurons were counted in the caudate nucleus and CA1 pyramidal cell layer and the percentage of neuronal damage was compared between the treated groups. In C57Bl/6J mice, there was less neuronal damage in the 17-estradiol–treated group compared with placebo group in the caudate nucleus (15 20% versus 39 27%, P = 0.02) and in the CA1 pyramidal cell layer (1.8 2% versus 10 14%, P = 0.08). In contrast, neuronal damage was not significantly different between the 17-estradiol and placebo groups in apoE-deficient mice in the caudate nucleus (47 35% versus 53 29%, P = 0.7) or in the CA1 pyramidal cell layer (24 19% versus 24 19%, P = 1.0). The data indicate a neuroprotective role for estrogen in global ischemia, the mechanism of which is apoE-dependent.

AB - Estrogen can ameliorate brain damage in experimental models of focal cerebral ischemia. In vitro, estrogen increases levels of apolipoprotein E (apoE), which also has neuroprotective effects in brain injury. The authors tested the hypotheses that physiologically relevant levels of 17-estradiol are neuroprotective in global cerebral ischemia and that neuroprotection is mediated via apoE. In the first study, subcutaneous implants of 17-estradiol were tested in female C57Bl/6J mice (ovariectomized and nonovariectomized) and plasma levels measured by radioimmunoassay to validate that physiologically relevant levels could be achieved. In the second study, female C57Bl/6J and apoE-deficient mice were ovariectomized and implanted with 17-estradiol or placebo pellet. Two weeks later, transient global ischemia was induced by bilateral carotid artery occlusion and the mice killed after 72 hours. Ischemic and normal neurons were counted in the caudate nucleus and CA1 pyramidal cell layer and the percentage of neuronal damage was compared between the treated groups. In C57Bl/6J mice, there was less neuronal damage in the 17-estradiol–treated group compared with placebo group in the caudate nucleus (15 20% versus 39 27%, P = 0.02) and in the CA1 pyramidal cell layer (1.8 2% versus 10 14%, P = 0.08). In contrast, neuronal damage was not significantly different between the 17-estradiol and placebo groups in apoE-deficient mice in the caudate nucleus (47 35% versus 53 29%, P = 0.7) or in the CA1 pyramidal cell layer (24 19% versus 24 19%, P = 1.0). The data indicate a neuroprotective role for estrogen in global ischemia, the mechanism of which is apoE-dependent.

KW - estrogen

KW - injury

KW - Alzheimer's disease

KW - apolipoprotein E

KW - neuroprotection

KW - global ischemia

U2 - 10.1097/01.wcb.0000037991.07114.4e

DO - 10.1097/01.wcb.0000037991.07114.4e

M3 - Article

VL - 22

SP - 1189

EP - 1195

JO - Journal of Cerebral Blood Flow and Metabolism

T2 - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 10

ER -